Melanie M. Hagleitner

Author

Also Known As

Hagleitner, M.M., Hagleitner, Melanie, Janneke H. P. Evers, M M Hagleitner, M. Hagleitner, M. M. Hagleitner, M.M. Hagleitner, Maëlle de Ville, Melanie Hagleitner, Melanie M Hagleitner

Publications

724

Citations

H-Index

Concepts

All Affiliations

Radboud University Medical Center Radboud University Nijmegen Princess Máxima Center Leiden University Medical Center Radboud Institute for Molecular Life Sciences

About

Melanie M. Hagleitner is an author at Radboud University Medical Center specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	97
2	Pathology	3	3	97
3	Blood Transplantation	1	1	44
4	Immunology	1	1	44
5	Marrow Transplantation	1	1	44

Melanie M. Hagleitner

Publications

433

Citations

H-Index

Page 1

	Year	Citations
Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome) Melanie M. Hagleitner, Arjan C. Lankester, P Maraschio, Journal of Medical Genetics	2007	215
A First Step toward Personalized Medicine in Osteosarcoma: Pharmacogenetics as Predictive Marker of Outcome after Chemotherapy-Based Treatment Melanie M. Hagleitner, Marieke J. H. Coenen, Hans Gelderblom, Clinical Cancer Research	2015	45
Hematopoietic Stem Cell Transplantation Corrects the Immunologic Abnormalities Associated With Immunodeficiency–Centromeric Instability–Facial Dysmorphism Syndrome Andrew R. Gennery, Mary Slatter, Robbert G. M. Bredius, PEDIATRICS ImmunodeficienciesImmunologyPathologyVariable ImmunodeficiencyImmunotherapy	2007	44
Survival Trends and Long-Term Toxicity in Pediatric Patients with Osteosarcoma Melanie M. Hagleitner, Eveline S.J.M. de Bont, D. Maroeska W. M. te Loo Sarcoma	2012	39
Age as prognostic factor in patients with osteosarcoma Melanie M. Hagleitner, Peter M. Hoogerbrugge, Winette T.A. van der Graaf, Bone Bone DiseaseLongevityPrognostic FactorMedicinePrognosis	2011	39
Taqman genotyping assays can be used on decalcified and paraffin‐embedded tissue from patients with osteosarcoma Melanie M. Hagleitner, Marieke J. H. Coenen, Judith W. M. Jeuken, Pediatric Blood & Cancer	2010	15
Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement Emma Kroeze, Laura Padilla, Max Bakker, Cancers Hematological MalignancyLymphoid NeoplasiaBcp-lbl PatientsPediatric HematologyMedicine	2022	14
Dosage of 6-Mercaptopurine in Relation to Genetic TPMT and ITPA Variants: Toward Individualized Pediatric Acute Lymphoblastic Leukemia Maintenance Treatment Theodorus W. Kouwenberg, B.J.C. van den Bosch, Jörgen Bierau, Journal of Pediatric Hematology/Oncology	2019	11
Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxicities Evelien G. E. Hurkmans, Marije J. Klumpers, Sita H. Vermeulen, Frontiers in Pharmacology	2020	11

Page 1